App B1

Save As...

Reset

Federal Register / Vol. 76, No. 159 / Wednesday, August 17, 2011 / Notices
physical substances, or mixtures
(collectively referred to as ‘‘substances’’)
cause adverse health effects and
provides opinions on whether these
substances may be of concern given
what is known about current human
exposure levels. Assessments of
potential adverse effects of
environmental substances on
reproduction or development carried
out by CERHR from 1998–2010 are now
conducted by OHAT. OHAT also
organizes workshops or state-of-thescience evaluations to address issues of
importance in environmental health
sciences. OHAT assessments are
published as NTP Monographs.
Information about OHAT is found
http://ntp.niehs.nih.gov/go/ohat.
NTP panels are technical, scientific
advisory bodies established on an ‘‘as
needed’’ basis to provide independent
scientific peer review and advise the
NTP on agents of public health concern,
new/revised toxicological test methods,
or other issues. These panels help
ensure transparent, unbiased, and
scientifically rigorous input to the
program for its use in making credible
decisions about human hazard, setting
research and testing priorities, and
providing information to regulatory
agencies about alternative methods for
toxicity screening. The NTP welcomes
nominations of scientific experts for
upcoming panels. Scientists interested
in serving on an NTP panel should
provide a current curriculum vitae to
Dr. Lori White (see ADDRESSES). The
authority for NTP panels is provided by
42 U.S.C. 217a; section 222 of the Public
Health Service (PHS) Act, as amended.
The panel is governed by the Federal
Advisory Committee Act, as amended
(5 U.S.C. Appendix 2), which sets forth
standards for the formation and use of
advisory committees.
Dated: August 8, 2011.
John R. Bucher,
Associate Director, National Toxicology
Program.
[FR Doc. 2011–20958 Filed 8–16–11; 8:45 am]
BILLING CODE 4140–01–P

Emcdonald on DSK2BSOYB1PROD with NOTICES

Designation of a Class of Employees
for Addition to the Special Exposure
Cohort
National Institute for
Occupational Safety and Health
(NIOSH), Department of Health and
Human Services (HHS).

AGENCY:

Notice.

VerDate Mar<15>2010

18:13 Aug 16, 2011

Save As...

All employees of the Department of
Energy, its predecessor agencies, and its
contractors and subcontractors who worked
in any area at the Sandia National
Laboratories in Albuquerque, New Mexico,
from January 1, 1949 through December 31,
1962, for a number of work days aggregating
at least 250 work days, occurring either
solely under this employment, or in
combination with work days within the
parameters established for one or more other
classes of employees in the Special Exposure
Cohort.

This designation will become
effective on September 9, 2011, unless
Congress provides otherwise prior to the
effective date. After this effective date,
HHS will publish a notice in the
Federal Register reporting the addition
of this class to the SEC or the result of
any provision by Congress regarding the
decision by HHS to add the class to the
SEC.
FOR FURTHER INFORMATION CONTACT:
Stuart L. Hinnefeld, Director, Division
of Compensation Analysis and Support,
National Institute for Occupational
Safety and Health (NIOSH), 4676
Columbia Parkway, MS C–46,
Cincinnati, OH 45226, Telephone 877–
222–7570. Information requests can also
be submitted by e-mail to
[email protected].
John Howard,
Director, National Institute for Occupational
Safety and Health.
[FR Doc. 2011–20925 Filed 8–16–11; 8:45 am]
BILLING CODE 4163–19–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

ACTION:

HHS gives notice of a
decision to designate a class of
employees from Sandia National
Laboratories in Albuquerque, New
Mexico, as an addition to the Special
Exposure Cohort (SEC) under the Energy
Employees Occupational Illness
Compensation Program Act of 2000. On
July 29, 2011, the Secretary of HHS
designated the following class of
employees as an addition to the SEC:

SUMMARY:

Jkt 223001

[60Day–11–08AJ]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic

PO 00000

Frm 00045

Fmt 4703

Sfmt 4703

51035

summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 or send
comments to CDC Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
[email protected].
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Focus Group Testing to Effectively
Plan and Tailor Cancer Prevention and
Control Communication Campaigns
(OMB No. 0920–0800, exp. 1/31/2012)—
Extension—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The mission of the CDC’s Division of
Cancer Prevention and Control (DCPC)
is to reduce the burden of cancer in the
United States through cancer
prevention, reduction of risk, early
detection, better treatment, and
improved quality of life for cancer
survivors. Toward this end, the DCPC
supports the scientific development,
implementation, and evaluation of
various health communication
campaigns with an emphasis on specific
cancer burdens. This process requires
testing of messages, concepts, and
materials prior to their final
development and dissemination, as
described in the second step of the
health communication process, a
scientific model developed by the U.S.
Department of Health and Human
Services’ National Cancer Institute to
guide sound campaign development.
CDC is currently approved to collect
information for these purposes (OMB
No. 0920–0800, exp. 1/31/2012). A
three-year extension of the existing
generic approval is requested.
The communication literature
supports various data collection
methods to conduct credible formative,

E:\FR\FM\17AUN1.SGM

17AUN1

Save As...

51036

Federal Register / Vol. 76, No. 159 / Wednesday, August 17, 2011 / Notices

concept, message, and materials testing,
one of which is focus groups. The
purpose of focus groups is to ensure that
the public and other key audiences, like
health professionals, clearly understand
cancer-specific information and
concepts, are motivated to take the
desired action, and do not react
negatively to the messages.
Information collection will involve
focus groups to assess numerous
qualitative dimensions of cancer
prevention and control messages,
including, but not limited to,
knowledge, attitudes, beliefs, behavioral
intentions, information needs and
sources, and compliance to

Screening Form ................................

1,728

1

3/60

86

Focus Group Discussion Guide .......
...........................................................

864
........................

1
........................

2
........................

1728
1814

Health care providers and general
public.

Dated: August 10, 2011.
Daniel Holcomb,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2011–20920 Filed 8–16–11; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–11–0802]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Daniel Holcomb, CDC
Reports Clearance Officer, 1600 Clifton
Road, MS–D74, Atlanta, GA 30333 or
send an e-mail to [email protected].
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the

18:13 Aug 16, 2011

Save As...

Average burden per response (in
hours)

Number of responses per
respondent

Form name

VerDate Mar<15>2010

discussion guides for a variety of focus
groups.
The average burden for each focus
group discussion will be two hours.
DCPC will conduct or sponsor up to 72
focus groups per year over a three-year
period. An average of 12 respondents
will participate in each focus group
discussion. A separate information
collection request will be submitted to
OMB for approval of each focus group
activity.
There are no costs to respondents
except their time. The total estimated
annualized burden hours are 1,814.
Estimated Annualized Burden Hours:

Number of respondents

Type of respondents

Total ...........................................

Emcdonald on DSK2BSOYB1PROD with NOTICES

recommended screening intervals.
Insights gained from the focus groups
will assist in the development and/or
refinement of future campaign messages
and materials. Respondents will include
health care providers as well as
members of the general public.
Communication campaigns will vary
according to the type of cancer, the
qualitative dimensions of the message
described above, and the type of
respondents. DCPC has developed a set
of example questions that can be
tailored to screen for targeted groups of
respondents, and a set of example
questions that can be used to develop

Jkt 223001

agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Active Bacterial Core Surveillance
(ABCs) Projects—OMB 0920–0802,
Expiration January 31, 2012
(Revision)—National Center for
Immunization and Respiratory Disease
(NCIRD), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
CDC is requesting a revision to the
approved data collection instruments
for Active Bacterial Core surveillance
(ABCs), to add supplemental questions
for invasive methicillin-resistant
Staphylococcus aureus (MRSA). CDC
requests OMB approval to collect
supplemental information to assess risk
factors for invasive MRSA among
patients recently discharged from acute
care hospitals. Seventeen acute care
facilities in 7 ABCs/EIP sites (CA, CT,
CO, GA, NY, MN, TN) will participate
in the collection of supplemental
information for ABCs MRSA.
Preventing healthcare-associated
invasive MRSA infections is one of
CDC’s priorities. Essential steps in

PO 00000

Frm 00046

Fmt 4703

Sfmt 4703

Total burden
(in hours)

reducing the occurrence of healthcareassociated invasive MRSA infections are
to quantify the burden and to identify
modifiable risk factors associated with
invasive MRSA disease. The current
ABCs MRSA surveillance has been
essential to quantify the burden of
invasive MRSA in the United States.
Through this surveillance CDC was able
to estimate that 94,360 invasive MRSA
infections associated with 18,650 deaths
occurred in the United States in 2005.
The majority of these infections (58%)
had onset in the community or within
3 days of hospital admission and
occurred among individuals with recent
healthcare exposures (healthcareassociated community-onset [HACO]).
More recent data from the CDC’s EIP/
ABCs system have shown that two
thirds of invasive HACO MRSA
infections occur among persons who are
discharged from an acute care hospital
in the prior 3 months. Risk factors for
invasive MRSA infections postdischarge have not been well evaluated,
and effective prevention measures in
this population remain uncertain.
The goal of the supplemental
questions to be added to ABCs MRSA
surveillance is to assess risk factors for
invasive healthcare-associated MRSA
infections, which will inform the
development of targeted prevention
measures. This activity supports the
HHS Action Plan for elimination of
healthcare-associated infections. This
change will result in minimal impact on
the current public burden.

E:\FR\FM\17AUN1.SGM

17AUN1